Apellis Pharmaceuticals
APLS
APLS
142 hedge funds and large institutions have $2B invested in Apellis Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 72 increasing their positions, 37 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
7% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 15
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
1% less funds holding
Funds holding: 143 → 142 (-1)
Holders
142
Holding in Top 10
4
Calls
$8.24M
Puts
$6.76M
Top Buyers
| 1 | +$58M | |
| 2 | +$44.2M | |
| 3 | +$26.7M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$20.7M |
| 5 |
State Street
Boston,
Massachusetts
|
+$14.6M |
Top Sellers
| 1 | -$57.8M | |
| 2 | -$15.6M | |
| 3 | -$9.22M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$9.15M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$6.53M |